MedPath

Chlorhexidine

Generic Name
Chlorhexidine
Brand Names
Betasept, Hibiclens, Instillagel, Nupro Chlorhexidine, Oris, Oro-Clense, Paroex, Perichlor, Peridex, Periochip, Periogard, Prevora, X-pur
Drug Type
Small Molecule
Chemical Formula
C22H30Cl2N10
CAS Number
55-56-1
Unique Ingredient Identifier
R4KO0DY52L
Background

Chlorhexidine is a broad-spectrum antimicrobial biguanide used as a topical antiseptic and in dental practice for the treatment of inflammatory dental conditions caused by microorganisms. It is one of the most common skin and mucous membrane antiseptic agents in use today. The molecule itself is a cationic bis-guanide consisting of two 4-chlorophenyl rings and two biguanide groups joined by a central hexamethylene chain. Topical chlorhexidine for disinfection, as well as oral rinses for dental use, carries activity against a broad range of pathogens including bacteria, yeasts, and viruses.

Chlorhexidine was developed in the UK by Imperial Chemical Industries in the early 1950s and was introduced to the US in the 1970s. The FDA withdrew its approval for the use of chlorhexidine gluconate topical tincture 0.5%, due to a significant number of reports concerning chemical and thermal burns associated with the use of this product. Other formulations of chlorhexidine continue to be available.

Indication

Chlorhexidine is available over-the-counter in various formulations (e.g. solution, sponge, cloth, swab) as a topical antiseptic to sanitize prior to surgeries and/or medical procedures. Dental formulations, available by prescription only, include an oral rinse indicated for the treatment of gingivitis and a slow-release "chip" which is inserted into periodontal pockets and is indicated for the reduction of pocket depth in adult patients with periodontitis as an adjunct therapy to dental scaling and root planing procedures.

Associated Conditions
Aphthous ulcer, Catarrh of the throat, Chemotherapy Induced Oral Mucositis, Chronic Wounds, Decubitus Ulcer, Dental Cavity, Dysphagia, Eczema infected, Foeter Ex Ore, Gingival Bleeding, Gingival Diseases, Gingivitis, Glossitis, Hoarseness, Infection, Infectious Periodontal Diseases, Injury Throat, Mild to Moderate Inflammatory Reaction of the Oral Cavity, Mild to Moderate Inflammatory Reaction of the Pharynx, Mouth injury, Mucositis, Neurodermatitis, Ocular Inflammation, Ocular Irritation, Oral Aphthous Ulcer, Pain, Periodontitis, Pharyngitis, Plaque, Dental, Postoperative Wound Infection, Purulent Gingivitis, Radiation Mucositis, Red eye, Ringworm, Skin Infections, Sore Throat, Stomatitis, Surgical Wounds, Tissue Damage, Tonsillitis, Ulcers, Leg, Wound Infections, Bacterial skin infections, Dry, cracked skin, Gum pain, Moderate Gingivitis, Oral infections, Oral lesions, Recurrent Oral fungal infection, Severe Gingivitis, Superficial Wounds, Throat disinfection, Tongue inflammation
Associated Therapies
Anesthesia of Mucous Membrane, Antimicrobial Therapy, Contact Lens Care, Disinfection, Disinfection of External Genitalia, Disinfection of the Urethra, Disinfection of the Vaginal Mucosa, Irrigation therapy, Lubrication of the Urethra, Oral Care, Oral Hygiene, Oropharyngeal antisepsis, Promotion of wound healing, Skin disinfection, Surgical Scrubbing, Topical Antisepsis, Urethral Anesthesia, Wound Cleansing, Oral antisepsis, Oral disinfection

Decolonization to Reduce After-Surgery Events of Surgical Site Infection

Phase 4
Recruiting
Conditions
Surgical Site Infection
Interventions
Drug: Soap Without Antiseptic Properties (Placebo)
Drug: Placebo Nasal Ointment
First Posted Date
2022-10-19
Last Posted Date
2024-08-26
Lead Sponsor
University of California, Irvine
Target Recruit Count
2700
Registration Number
NCT05586776
Locations
🇺🇸

Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States

🇺🇸

University of California, San Francisco Medical Center, San Francisco, California, United States

🇺🇸

University of California, Irvine Medical Center, Orange, California, United States

and more 1 locations

Hydroxylated Polymethoxy Flavones Solid Dispersion in Treatment of Periodontitis

Phase 1
Not yet recruiting
Conditions
Inflammatory Disease
Periodontal Diseases
Interventions
Procedure: scaling and root planing
Drug: placebo
Drug: hydroxylated poly methoxy flavones
First Posted Date
2022-09-21
Last Posted Date
2023-10-10
Lead Sponsor
Assiut University
Target Recruit Count
30
Registration Number
NCT05546788

Evaluation of the Efficacy of Mouth Rinses With Commercial Mouthwashes to Decrease Viral Load in Saliva in COVID-19 Patients

Not Applicable
Completed
Conditions
covid19
Interventions
Drug: Lacer Clorhexidine 0.20% Colutorio
Drug: Gingilacer Encías Delicadas Colutorio
First Posted Date
2022-09-16
Last Posted Date
2022-09-16
Lead Sponsor
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Target Recruit Count
48
Registration Number
NCT05543603
Locations
🇪🇸

Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain

🇪🇸

Hospital Universitario Infanta Elena, Madrid, Spain

🇪🇸

Hospital Universitario General de Villalba, Madrid, Spain

and more 1 locations

Dental Biofilm Control During Orthodontic Treatment

Phase 3
Recruiting
Conditions
Gingivitis
Malocclusion
Interventions
Device: fixed metal orthodontic appliance
Device: fixed non-metal orthodontic appliance
Procedure: oral hygiene
First Posted Date
2022-09-08
Last Posted Date
2024-12-30
Lead Sponsor
University of Rijeka
Target Recruit Count
80
Registration Number
NCT05532241
Locations
🇭🇷

University of Rijeka Faculty of Dental Medicine, Rijeka, Croatia

🇭🇷

University of Rijeka, Faculty od Dental Medicine, Dental Clinic, Rijeka, Croatia

🇭🇷

University of Rijeka, Faculty of Dental Medicine, Rijeka, Croatia

Randomized Controlled Trial Comparing Irrisept Versus Normal Saline for Wound Irrigation After Posterior Spine Surgery

Phase 4
Withdrawn
Conditions
Cervical Spine Degeneration
Lumbar Spine Degeneration
Interventions
First Posted Date
2022-06-07
Last Posted Date
2022-12-27
Lead Sponsor
University of Missouri-Columbia
Registration Number
NCT05408923
Locations
🇺🇸

Missouri Orthopaedic Institute, Columbia, Missouri, United States

Skin Preparation for Elective Foot and Ankle Surgery

Phase 4
Recruiting
Conditions
Microbial Colonization
Foot and Ankle Disorders
Interventions
Drug: Isopropyl Alcohol 70% Topical Application Solution
First Posted Date
2022-06-02
Last Posted Date
2025-04-25
Lead Sponsor
University of Missouri-Columbia
Target Recruit Count
100
Registration Number
NCT05401292
Locations
🇺🇸

University of Missouri, Columbia, Missouri, United States

Evaluation of the Effect of Oil Pulling

Not Applicable
Completed
Conditions
Dental Plaque
Oral Hygiene
Interventions
Other: Distilled Water
Other: Oil Pulling
First Posted Date
2022-03-31
Last Posted Date
2022-03-31
Lead Sponsor
Ataturk University
Target Recruit Count
100
Registration Number
NCT05304338
Locations
🇹🇷

Ataturk University, Erzurum, None Selected, Turkey

Title: Comparison of Anti-plaque Efficacy of Natural Honey With Chlorhexidine Mouthwash: A Randomized Controlled Trial

Phase 1
Completed
Conditions
Dental Plaque
Interventions
Other: Natural honey
First Posted Date
2022-02-28
Last Posted Date
2022-02-28
Lead Sponsor
Liaquat National Hospital & Medical College
Target Recruit Count
60
Registration Number
NCT05258955
Locations
🇵🇰

Liaquat College of Medicine and Dentistry, Karachi, Sindh, Pakistan

OZOCLO_MUCOSITIS: a New Protocol for Prevention of Oral Mucositis

Phase 4
Conditions
Mucositis (MeSH Unique ID: D052016)
Stomatitis (MeSH Unique ID: D013280)
Interventions
Drug: 4. sodium bicarbonate 5% solution - mouthwash
Drug: 1. alpha acid lipoic - tables
Drug: 2. ozonated oil - mouthwash
First Posted Date
2022-01-27
Last Posted Date
2022-01-27
Lead Sponsor
University of Palermo
Target Recruit Count
80
Registration Number
NCT05211622

Short- and Long Term Antibacterial Effects of a Single Rinse With Different Mouthwashes: a Randomized Clinical Trial

Phase 4
Completed
Conditions
Caries
Gingival Diseases
Interventions
First Posted Date
2022-01-05
Last Posted Date
2022-02-24
Lead Sponsor
Semmelweis University
Target Recruit Count
171
Registration Number
NCT05178823
Locations
🇭🇺

Semmelweis University, Budapest, Hungary

© Copyright 2025. All Rights Reserved by MedPath